There has been controversy around aducanumab, which targets the cause rather than the symptoms.
from BBC News - US & Canada https://ift.tt/3g11rwc
lundi 7 juin 2021
SportUS approves first new Alzheimer's drug in 20 years
Inscription à :
Publier les commentaires (Atom)
0 commentaires:
Enregistrer un commentaire